V-CARD
PHONE
+32 2 505 0913
FAX
+32 2 505 0996
|
|
Alexander
Roussanov
Associate, Brussels
alexander.roussanov@hoganlovells.com
Alexander Roussanov concentrates on pharmaceutical and medical devices matters, with a particular focus on the EU regulatory framework.
Alexander advises in the areas of EU and national regulatory regimes regarding medicinal products and medical devices, including promotion and marketing of products, compliance of communication and interactions with stakeholders, regulatory obligations related to authorization, and placing on the market.
He has also worked in the field of national pricing and reimbursement systems. Issues include the transposition of the EU Price Transparency Directive, compliance of national pricing and reimbursement policies, and implications on the free movement of goods and services in this area.
Alexander also has experience in developing and analyzing EU institutions’ policies and decision making processes, including input into the process of adoption of EU legislation touching upon the pharmaceuticals sector, policy discussions, and stakeholders relations.
Other areas that Alexander had exposure to include the enforcement of Intellectual Property Rights in EU Member States, sales agreements, and antitrust issues specific to the pharmaceutical sector.
Prior to joining Hogan & Hartson, Alexander worked at the European Public Affairs office of a leading international pharmaceutical company.
Hogan Lovells Publications
29 April 2010
"EU Court of Justice: National Authorities Permitted to Provide Inducements to Healthcare Professionals." Pharmaceutical and Biotechnology Update, Hogan & Hartson LLP
01 June 2009
"Uncertainty Remains as to the Practical Impact of Revision of the EU Medical Devices Directive on Existing Certificates of Conformity as the Deadline for Enforcement of the Revision Approaches." Pharmaceutical and Biotechnology Update, Hogan & Hartson LLP
07 May 2009
"The European Court of Justice Adopts Stricter Approach to the Promotion of Medicinal Products and the Scope of the Term 'Advertising'." Pharmaceutical and Biotechnology Update, Hogan & Hartson LLP
Published Works
February 2010
"Understanding the Promotion of Medical Devices in the European Union." Journal of Medical Device Regulation
|
|
|